Swiss Cancer Center Léman (SCCL)

Connected institutions, collaborative specialisations

The Swiss Cancer Center Léman (SCCL) is an alliance created by and amongst the leading institutions that are the : Lausanne University Hospital (CHUV), the University Hospitals of Geneva (HUG), the Universities of Lausanne and Geneva, the Swiss Federal Institute of Technology in Lausanne (EPFL) and its partners (see below).

Under a single inclusive identity, this consortium brings together the region's key actors in cancer care, from bench to bedside. 

Innovation through Interaction

By focusing efforts on the leading edge of their respective fields, the objective of the alliance members is to develop precision and predictive medical care, one that will recast the treatment of cancer patients.  

Executive committee

George Coukos

Pr George Coukos

Head of Service of immuno-oncology
Head of Department of oncology UNIL CHUV
Director, Ludwig Institute for Cancer Research Lausanne branch
+41 21 314 13 57

Curriculum Vitae
Elisa Oricchio

Pr Elisa Oricchio

Director of ISREC – Swiss Institute for Experimental Cancer Research at the EPFL

Curriculum Vitae
Olivier Michielin

Pr Olivier Michielin

Head of Oncology department HUG
Head of Precision oncology service HUG
Professor at the Faculty of Medicine UNIGE

Curriculum Vitae

The CHUV's specificity within the SCCL

The UNIL CHUV Oncology department underpins the SCCL's mission to develop innovative treatments, notably via its immunotherapy programme. Its Immuno-oncology service is dedicated to early phase clinical research. 

SCCL members with the CHUV

SCCL partners

The SCCL is set in the imposing regional context of the "Health Valley" which includes 450 biotech and 300 medtech firms, 500 biomedical research laboratories and 8 incubators. It is also part of the BioAlps network, backed by the six French-speaking regions of Switzerland, that of Berne (federal government) and the Swiss Confederation. 


 Last updated on 31/01/2023 at 15:32